Neogenomics, Inc. share price logo

Neogenomics, Inc. Share Price

NASDAQ: NEO

Mid Cap

$7.96

-0.38

(-4.56%)

as on

Neogenomics, Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $7.91
    $8.38
    downward going graph

    0.63%

    Downside

    5.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.72
    $19.12
    downward going graph

    40.70%

    Downside

    140.14%

    Upside

    downward going graph

Neogenomics, Inc. share price movements today

Previous Close
$8.34
Open
$8.38
Volume
1.7M
Day's Low - High
$7.91 - $8.38
52 Week Low - High
$4.72 - $19.12

Neogenomics, Inc. Historical Returns

1 Month Return
+ 27.56 %
3 Month Return
+ 12.59 %
1 Year Return
-51.46 %
3 Year Return
-20.64 %
5 Year Return
-77.48 %

Neogenomics, Inc. Stock Fundamentals & Key Indicators

Check Neogenomics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

0.0992

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.31%

PE Ratio (TTM)

-26.79

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

3.02

EBITDA

-7.8M

Revenue (TTM)

689.2M

Profit Margin

-15.10%

Return On Equity TTM

16253500.00%

Neogenomics, Inc. Stock Valuation

Track how Neogenomics, Inc. P/E has moved over time to understand its valuation trends.

Neogenomics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 13, 2025

Today (-26.79x)

September 13, 2025

Industry (10.13x)

September 13, 2025

Highest (0.00x)

September 13, 2025

LowHigh

Today’s Price to Earnings Ratio: -26.79x

Neogenomics, Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Neogenomics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.0B-77.48%-26.79-15.10%

Stock Returns calculator for Neogenomics, Inc. Stock including INR - Dollar returns

The Neogenomics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neogenomics, Inc. investment value today

Current value as on today

₹53,676

Returns

₹46,324

(-46.32%)

Returns from Neogenomics, Inc. Stock

₹51,463 (-51.46%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Neogenomics, Inc. Stock

Based on 17 analysts

BUY

76.47%

Buy

23.53%

Hold

0.00%

Sell

Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Neogenomics, Inc.. Average target price of $10

Neogenomics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Neogenomics, Inc..

What analysts predicted

20.4%UPSIDE

Target Price

$10

Current Price

$7.96

Analyzed by

17 Analysts

Target

$10.00

Neogenomics, Inc. target price $10, a slight upside of 20.4% compared to current price of $7.96. According to 17 analysts rating.

Neogenomics, Inc. Stock's Interest Amongst Investors

Investment in Neogenomics, Inc. Shares on INDmoney has dropped by -33.92% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-33.92% versus previous 30 day period

Search interest for Neogenomics, Inc. Stock has increased by 69% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:69% versus previous 30 day period

Neogenomics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
137
146
151
155
156
164
167
172
168
181
Gross Profit
54
59
62
67
65
72
74
77
73
77
Operating Income
-35
-29
-24
-18
-30
-21
-21
-18
-27
-47
EBITDA
-14
-6
-1
4
-7
0
1
3
-6
-47
Interest Expense
1
1
1
1
1
1
1
1
1
0
Depreciation
17
18
18
18
18
18
17
18
17
17
Income Before Tax
-33
-26
-21
-15
-27
-19
-17
-16
-25
-45
Income Tax Expense
-2
-2
-2
0
0
0
0
0
0
0
Net Income
-30
-24
-18
-14
-27
-18
-17
-15
-25
-45
Net Profit Margin
-22.44%
-16.56%
-12.19%
-9.21%
-17.32%
-11.33%
-10.55%
-8.91%
-15.43%
-24.87%

Neogenomics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
99
244
240
276
408
444
484
509
591
660
Gross Profit
43
110
101
127
196
185
187
187
244
290
Operating Income
-5
2
2
10
13
-13
-118
-157
-107
-92
EBITDA
3
25
26
31
43
34
-65
-82
-17
-1
Interest Expense
0
9
5
6
3
7
8
7
6
6
Depreciation
-
-
22
21
30
35
53
69
72
72
Income Before Tax
-4
-7
-2
3
3
-14
-15
-159
-97
-80
Income Tax Expense
-1
-1
-2
1
-4
-18
-6
-15
-9
-1
Net Income
-2
-6
0
2
8
4
-8
-144
-87
-78
Net Profit Margin
-2.54%
-2.52%
-0.16%
0.95%
1.96%
0.94%
-1.72%
-28.30%
-14.87%
-11.92%

Neogenomics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-24
-18
-14
-27
-18
-17
-15
-25
-45
Operating Cash Flow
-1
-5
17
-25
13
9
9
-25
20
Investing Cash Flow
14
20
17
14
7
-3
-5
3
-9
Financing Cash Flow
0
1
1
0
1
1
0
0
-202
Change in Cash
13
17
36
-10
23
6
5
-20
-191

Neogenomics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-5
0
2
8
4
-8
-144
-87
-78
Operating Cash Flow
21
18
44
23
1
-26
-65
-1
7
Investing Cash Flow
-6
-13
-139
-19
-159
-632
0
76
12
Financing Cash Flow
-25
-4
91
159
235
725
11
4
4
Change in Cash
-10
0
-3
163
77
66
-53
79
24

Global Institutional Holdings in Neogenomics, Inc.

Funds
Holdings
BlackRock Inc
15.38%
Vanguard Group Inc
11.04%
Millennium Management LLC
5.2%
First Light Asset Management, LLC
4.68%
HHG PLC
4.44%

Insights on Neogenomics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NEO stock has moved up by 27.6%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 168.03M → 181.33M (in $), with an average increase of 7.3% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 51.95% to 52.97% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Idexx Laboratories, Inc. has given 83.0% return, outperforming this stock by 103.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Idexx Laboratories, Inc. has given 28.1% return, outperforming this stock by 79.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 47.03% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.02% to 0.00% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -15.32M → -45.09M (in $), with an average decrease of 71.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NEO stock has moved down by -3.0%

About Neogenomics, Inc.

neogenomics laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. we work every day to achieve our common purpose of saving lives by improving patient care through communication, accuracy, reliability, and efficiency. our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor fish testing with the largest menu of technical-only services available; 10-color flow cytometry; ihc supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out fish, flow cytometry, and/or ihc. neogenomics’ extremely fast test development cycle means we are hig
OrganisationNeogenomics, Inc.
Headquarters9490 NeoGenomics Way, Fort Myers, FL, United States, 33912
IndustryHealth Services
CEOMr. Anthony P. Zook
E-voting on sharesClick here to vote

Key Management of Neogenomics, Inc.

Name

Title

Ms. Kendra Sweeney

Vice President of Investor Relations & Communications

Mr. Hutan Hashemi J.D.

Chief Compliance Officer

Mr. Gary Passman

Chief People & Culture Officer

Ms. Alicia C. Olivo

Executive VP of Business Development, General Counsel & Corporate Secretary

Mr. Gregory D. Aunan

Senior VP & Chief Accounting Officer

Mr. Jeffrey S. Sherman M.B.A.

Chief Financial Officer

Ms. Elizabeth A. Floegel

Chief Digital & Information Officer

Mr. Kareem M. Saad

Head of Strategy, Business Development & Transformation

Mr. Anthony P. Zook

CEO & Director

Mr. Warren Stone

President & COO

FAQs

What is Neogenomics, Inc. share price today?

Neogenomics, Inc. share price today is $7.96 as on at the close of the market. Neogenomics, Inc. share today touched a day high of $8.38 and a low of $7.91.

What is the 52 week high and 52 week low for Neogenomics, Inc. share?

Neogenomics, Inc. share touched a 52 week high of $19.12 on and a 52 week low of $4.72 on . Neogenomics, Inc. stock price today i.e. is closed at $7.96,which is 58.36% down from its 52 week high and 68.64% up from its 52 week low.

What is Neogenomics, Inc.'s market capitalisation today?

Neogenomics, Inc. market capitalisation is $0.00T as on .

How to invest in Neogenomics, Inc. Stock (NEO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neogenomics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neogenomics, Inc. Shares that will get you 0.1884 shares as per Neogenomics, Inc. share price of $7.96 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Neogenomics, Inc. Stock (NEO) from India?

Indian investors can start investing in Neogenomics, Inc. (NEO) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Neogenomics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Neogenomics, Inc. share’s latest price of $7.96 as on September 13, 2025 at 1:29 am IST, you will get 1.2563 shares of Neogenomics, Inc.. Learn more about fractional shares .

What are the returns that Neogenomics, Inc. has given to Indian investors in the last 5 years?

Neogenomics, Inc. stock has given -77.48% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?